Clinico-epidemiological profile of patients with vitiligo: A retrospective study from a tertiary care center of North India

• Published in: Indian Dermatology Online Journal Vol. 10; no. 1; pp. 38 - 44
• Main Authors: Mahajan, Vikram, Vashist, Sanket, Chauhan, Pushpinder, Mehta, Karan, Sharma, Vikas, Sharma, Anuj
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.01.2019; Medknow Publications & Media Pvt Ltd; Wolters Kluwer Medknow Publications
• Subjects: Alopecia areata; autoimmune thyroiditis; Brief Report; Himachal Pradesh; Koebner's phenomenon; leukotrichia; psoriasis; vitiligo vulgaris; vitiligo vulgaris; leukotrichia; Himachal Pradesh; autoimmune thyroiditis; Koebner's phenomenon; psoriasis; Alopecia areata
• ISSN: 2229-5178; 2249-5673
• DOI: 10.4103/idoj.IDOJ_124_18

Background: We studied clinico-epidemiological features of 945 patients with vitiligo with an objective to delineate epidemiological and clinical aspects of vitiligo from this part of the country. Materials and Methods: The medical records of patients with vitiligo attending outpatient clinic over a 5-year period from January 2013 to December 2017 were analyzed retrospectively for this descriptive, observational study. Results: There were 449 men and 496 women (m:f 1:1.1) aged between 2 and 83 years (mean 24.4 years) and having vitiligo for 1 week to 64 years (mean 5.1 years). The majority, 478 (50.6%) patients were aged ≤20 years and 248 (26.2%) were children aged ≤12 years. The age at the onset was between 6 months and 82 years (mean 20.5 years), and the majority 674 (71.3%) patients had it before 25 years of age. The consultation time was within 5 years in 692 (73.2%) patients. A family history of vitiligo was present in 150 (15.9%) patients. The majority 871 (92.2%) patients had involvement of up to 10% body surface area and vitiligo vulgaris in 562 (59.5%) and focal vitiligo in 117 (18.7%) patients were the most common clinical types. An association with other systemic disorders was in 124 (13.1%) patients and predominately included thyroid abnormalities and diabetes mellitus. Conclusions: Our observations are essentially consistent with the literature. There was no difference in clinico-epidemiological features of vitiligo. Patients with an affected first-degree family member had early onset, but difference was not statistically significant. Screening for concurrent thyroid disorders appears important. However, our inferences remain limited by single center, retrospective, observational, and cross-sectional nature of the study.